Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
10/04/2026
Herriot CEO: As long as the situation in the Middle East remains stable, we currently anticipate that there will not be a domino effect on trade in other regions.
Latest
4 m ago
Yuexiu Capital: It is expected that the net profit for the first quarter of 2026 will be between 12.47 billion and 13.79 billion yuan, a year-on-year increase of 90% to 110%.
5 m ago
Shanghai Stock Exchange: The limit on the price fluctuation of main board warning-listed stocks will be adjusted from 5% to 10%.
6 m ago
Liu Niu Mountain: In March 2026, the sales revenue of live pigs was 102 million yuan, an increase of 27.25% compared to the previous month, and a decrease of 6.36% compared to the same period last year.
6 m ago
Jincheng Pharmaceuticals: Subsidiary received certificate of registration for injectable erythromycin lactobionate drug.
7 m ago
Rongchang Biotechnology: The indication for the use of vedolizumab as first-line treatment for HER2-expressing urothelial carcinoma has been approved.
See all latest